Emerg Infect DisEmerging Infect. DisEIDEmerging Infectious Diseases1080-60401080-6059Centers for Disease Control and Prevention25530077428526114-076210.3201/eid2101.140762ResearchResearchClinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013Clinical, Environmental, and Serologic Surveillance Studies of
Melioidosis in Gabon, 2012–2013Melioidosis in Gabon,
2012–2013WiersingaW. Joost1BirnieEmma1WeehuizenTassili A.F.AlabiAbraham S.HusonMichaëla A.M.in ’t VeldRobert A. G. HuisMabalaHarry K.AdzodaGregoire K.Raczynski-HenkYannickEsenMeralLellBertrandKremsnerPeter G.VisserCaroline E.WuthiekanunVanapornPeacockSharon J.van der EndeArieLimmathurotsakulDirekGrobuschMartin P.University of Amsterdam, Amsterdam, the Netherlands (W.J. Wiersinga, E.
Birnie, T.A.F. Weehuizen, M.A.M. Huson, R.A.G. in ’t Veld, C.E. Visser, A. van
der Ende, M.P. Grobusch); Albert Schweitzer Hospital, Lambaréné, Gabon (A.S. Alabi,
H.K. Mabala, G.K. Adzoda, M. Esen, B. Lell, P.G. Kremsner, M.P. Grobusch); Ex-Situ Silex Geoarchaeology, Leiden, the Netherlands (Y.
Raczynski-Henk); University of Tübingen, Tübingen, Germany (M. Esen, B.
Lell, P.G. Kremsner, M.P. Grobusch); Mahidol University, Bangkok, Thailand (V. Wuthiekanun, D.
Limmathurotsakul); University of Cambridge, Cambridge, UK (S.J. Peacock)Address for correspondence: W. Joost Wiersinga, Center for Infection
and Immunity Amsterdam, Dept. of Internal Medicine, Academic Medical Center,
University of Amsterdam, Meibergdreef 9, Room G2-132, 1105 AZ Amsterdam, the
Netherlands; email: w.j.wiersinga@amc.uva.nl120152114047
Burkholderia pseudomallei and B. thailandensis are
in the soil; a novel B. pseudomallei sequence type causes lethal
septic shock.
Burkholderia pseudomallei, an environmental gram-negative bacillus,
is the causative agent of melioidosis and a bio-threat agent. Reports of B.
pseudomallei isolation from soil and animals in East and West Africa
suggest that melioidosis might be more widely distributed than previously thought.
Because it has been found in equatorial areas with tropical climates, we hypothesized
that B. pseudomallei could exist in Gabon. During 2012–2013,
we conducted a seroprevalance study in which we set up microbiology facilities at a
large clinical referral center and prospectively screened all febrile patients by
conducting blood cultures and testing for B. pseudomallei and
related species; we also determined whether B. pseudomallei could be
isolated from soil. We discovered a novel B. pseudomallei sequence
type that caused lethal septic shock and identified B. pseudomallei
and B. thailandensis in the environment. Our data suggest that
melioidosis is emerging in Central Africa but is unrecognized because of the lack of
diagnostic microbiology facilities.
The Tier 1 bio-threat agent Burkholderia pseudomallei is an environmental
gram-negative bacillus and the cause of melioidosis, a disease characterized by sepsis,
pneumonia, and abscess formation in almost any organ (1–3). B. thailandensis is closely related to
B. pseudomallei but rarely causes disease in humans or animals; it is
usually distinguished from B. pseudomallei by its ability to assimilate
arabinose (4–6). Melioidosis mainly affects those
who are in regular contact with soil and water and is associated with a mortality rate of
up to 40% in resource-poor environments. The major regions to which melioidosis is endemic
are Southeast Asia and tropical Australia (1,2).
The northern tip of the Northern Territory in Australia and northeast Thailand represent
hot spots, where annual incidence is up to 50 cases per 100,000 persons (1,7).
The emergence of melioidosis in Brazil is an example of increasing recognition of the
disease in areas where it is probably endemic, and cases have become apparent as a result
of enhanced awareness and diagnostics (1,8).
Human B. pseudomallei infection has been reported from Malawi, Nigeria,
The Gambia, Kenya, and Uganda; however, human cases in Africa seem to be few and isolated,
although this finding could be the result of underrecognition and underreporting (1,9–12). Although reports of B. pseudomallei
isolation from soil and animals in East and West Africa are limited, they suggest that
melioidosis could be widely distributed across this region (13,14).
Given the equatorial tropical distribution of B. pseudomallei and
B. thailandensis, we hypothesized that these bacteria are present in
the central African country of Gabon, potentially causing disease. By conducting a
seroprevalence study, an environmental survey, and setting up microbiology facilities for
B. pseudomallei detection at a large referral hospital, we detected
B. pseudomallei in soil and identified it as a cause of lethal
infection in Gabon. We also detected B. thailandensis in environmental
soil samples, indicating that this organism is also present in Gabon.
MethodsStudy Sites and Populations
The study was performed in Moyen-Ogooué and Ngounié Provinces (combined
population 162,000) in central Gabon; these 2 provinces cover an area of 56,285
km2 and consist of predominantly dense primary rain forest. For the
seroprevalence surveillance study, 304 serum samples were collected from healthy
nonfebrile school children (12–20 years of age) living in and around
Lambaréné, the capital of Moyen-Ogooué Province; these children
also participated in a chemoprophylaxis study for malaria (15).
A prospective analysis of community-acquired bloodstream infections was performed at
Albert Schweitzer Hospital (which admits ≈6,000 patients annually) in
Lambaréné (population 24,000), in the Central African rain forest on
the river Ogooué, Gabon. The rainy season starts in October and ends in June
(including a short dry season in December–January). Mean annual rainfall is
1,981 mm (78 inches), which is equivalent to that in northeastern Thailand (16). Studies were approved by
the Centre National de la Recherche Scientifique et Technologique, Libreville, and
the scientific review committee of the Centre de Recherches Médicales de
Lambaréné, Albert Schweitzer Hospital.
Prospective Analysis of Community-Acquired Bloodstream Infections
To obtain data about the prevalence and causes of community-acquired bloodstream
infections in Lambaréné, we prospectively monitored all blood cultures
for febrile patients admitted to Albert Schweitzer Hospital for 1 year (June 1,
2012–May 31, 2013) by using BacT/Alert PF (bioMérieux, Marcy
l'Etoile, France). Criteria for ordering blood cultures were left to the
discretion of the treating physician. Technicians and staff of the clinical
microbiology laboratory received additional training on sample handling and
processing (17,18). All oxidase-positive,
gram-negative bacteria that were not Pseudomonas aeruginosa were
further tested to determine whether they were B. pseudomallei by
using the subculture and identification methods described below. Antimicrobial drug
susceptibilities were determined by using Etest (bioMérieux) on
Mueller-Hinton-agar (bioMérieux); when available, break points were defined as
described (19).
B. pseudomallei Antibody Detection by Indirect Hemagglutination
Assay
During May 2012, presence and titer of antibodies to B. pseudomallei
in healthy schoolchildren were determined using by the indirect hemagglutination
assay (IHA) as described (20,21), with pooled antigens prepared from 2 B.
pseudomallei isolates from Thailand. An antibody titer of ≥1:40
was used as the cutoff value for seropositivity (22).
Soil Sampling Study
During July 2012–September 2012, soil sampling to test for the presence of
B. pseudomallei was based on consensus guidelines, and direct
culture of soil in enrichment broth was performed (17,23). A total of 8 sites around the residences of children
were selected on the basis of local maps and consultations with inhabitants
throughout the provinces of Moyen-Ogooué (6 sites) and Ngounié (2
sites) and on known factors associated with the presence of B.
pseudomallei (e.g., wet soil such as rice paddies or land use such as
goat farming) (17) (Figure 1). Within each sampling area (50 ×
50 m2), a fixed-interval sampling grid was used to collect 100 samples per
field, 5 m apart. For each sample, 10 g of soil was collected from a depth of 30 cm,
stored away from direct sunlight, and processed within 3 h.
Environmental survey. A) Gabon, showing location of the 8 sites from which soil
was sampled to test for the presence of B. pseudomallei, July
2012–September 2012. B) Soil sampling site no. H, a rice field near
Mouila village.
Isolation of potential Burkholderia spp. from soil was performed as
described (17,23). In brief, 10 g of soil was
diluted in 10 mL of threonine–basal salt solution plus colistin at 50 mg/liter
(TBSS-C50 broth) containing crystal violet and was vortexed for 30 s before
incubation at ≈42°C for 48 h. Ten μL of supernatant was
subcultured onto Ashdown-agar and incubated and examined every 24 h for 7 days.
B. pseudomallei was identified by colony morphology, positive
oxidase test result, inability to assimilate arabinose, antimicrobial drug
susceptibility pattern (B. pseudomallei is generally resistant to
gentamicin and colistin but susceptible to amoxicillin/clavulanic acid [1,2]), and results of API 20NE (bioMérieux) and
B. pseudomallei–specific (Bps) latex-agglutination tests
(18,24,25). Positive results were confirmed with molecular
analysis. Soil type was determined by standard lithologic and pedologic analysis of
sediments; for this purpose, 2 extra samples were collected per site from a depth of
30 cm (26). Sediment
properties were compared with properties of other (typical) samples from the same
locations as described in the recently published Soil Atlas of Africa (26).
Genetic and Phylogenetic Analyses
Genomic DNA was extracted by using a DNeasy Blood and Tissue Kit (QIAGEN, Valencia,
CA, USA) to perform multilocus sequence typing (MLST) (27). Primers used to amplify fragments of the 7
housekeeping genes were identical to those described at the
Burkholderia MLST website (http://bpseudomallei.mlst.net/misc/info2.asp). For isolate B.
thailandensis D50, the primer narK-up was replaced by narK-upAMC
5′-TCTCTACTCGTGCGCTGGGG-3′. Sequences of the 7 gene fragments of
isolates from Africa were concatenated and combined with those from a selection of
971 sequence types (STs) representing all B. pseudomallei,
B. mallei, and B. thailandensis isolates in the
B. pseudomallei MLST database. Concatenated sequences were
aligned and analyzed by using MEGA-6 (http://www.megasoftware.net).
A phylogenetic tree was constructed by using a neighbor-joining algorithm and the
Kimura 2-parameter model. Bootstrap testing was performed for 500 repetitions.
Whole-genome sequencing was performed by using the MiSeq platform (Illumina, San
Diego, CA, USA) as described (9).
ResultsCommunity-Acquired Bloodstream Infections
Of the 941 bacterial blood cultures, 77 (8.2%) were positive for bacteria. The most
prevalent isolate was Escherichia coli, responsible for 8 (10.0%)
bloodstream infections, followed by Staphylococcus aureus (6 [7.8%])
and Salmonella enterica (6 [7.8%], 5 of which were nontyphoidal
salmonellae). Other organisms that were isolated at least 5 times included
Streptococcus pneumoniae (5 [6.5%]), Klebsiella
pneumoniae (5 [6.5%]), and Enterobacter spp. (5 [6.5%]).
B. pseudomallei was isolated from 1 (1.4%) patient, described in
the case report.
Case Report
A 62-year-old Gabonese woman was hospitalized in January 2013 with a 7-day history of
fever, cough, weakness, headache, vomiting, and a painful knee. She did not report
coughing or shortness of breath. She had poorly controlled diabetes mellitus and was
taking glibenclamide. She had no history of cardiopulmonary or renal disease, was
receiving no long-term medications other than glibenclamide, and did not smoke. She
was a retired school teacher but still engaged in family farming. Physical
examination revealed blood pressure of 160/90 mm Hg, a pulse rate of 130 beats per
minute, and a temperature of 40.5°C. She had a wound with an underlying
abscess on her right leg, together with diffuse tenderness of the right knee with
warmth, erythema, and limitation of active and passive ranges of motion because of
pain and effusion. Neurologic, cardiovascular, and respiratory examinations revealed
no abnormalities. Laboratory findings obtained at admission showed an elevated blood
glucose level of 24 mmol/L but values within reference range for creatinine (0.85
mg/dL), leukocytes (9,800 × 103 mm3), and hemoglobin
(9.2 g/dL). No other blood or urine test was performed, and chest radiographs were
not taken. On hospitalization day 1, treatment with amoxicillin/clavulanic acid was
empirically initiated for sepsis. On day 2, the abscess was incised and drained, and
on day 3 antimicrobial drug therapy was switched to ceftriaxone. Cultures of blood,
wound, and synovial fluid grew identical gram-negative rods, which were initially
classified as Pseudomonas spp. No other pathogens were detected. The
patient’s clinical condition deteriorated, and she died of septic shock on day
8. A postmortem examination was not performed.
After the patient’s death, the Pseudomonas species was
classified as B. pseudomallei (patient strain Gb100) and confirmed
by MLST and whole-genome sequencing. This isolate was later determined to be
susceptible to trimethoprim/sulfamethoxazole, amoxicillin/clavulanic acid,
ceftazidime, and meropenem (Table
1).
Antimicrobial drug susceptibility of Burkholderia
pseudomallei and B. thailandensis strains from
Gabon, 2012–2013*
Drug
MIC,
mg/L
Break point
resistance
B.
pseudomallei patient strain
B.
pseudomallei soil strain C2
B.
thailandensis soil strain D50
Amikacin
4†
96
96
128
Tobramycin
4†
16
24
24
Ciprofloxacin
1
0.75
1.0
0.5
Moxifloxacin
1‡
0.75
0.75
0.75
Meropenem
4
0.75
0.75
0.75
Ceftazidime
8
2
2
2
TMP/SMX
1/19
1
1
1
AMC
8/2
4
4
6
TZP
32/?§
1.5
1.5
3
Chloramphenicol
8
3
3
3
Tetracycline
4¶
1.5
2
8
Polymyxin B
NA#
>1,024
>1,024
>1,024
*Bacterial isolates were tested for their susceptibility to antimicrobial
agents. MIC (MICs; mg/L) were determined by E-test on Mueller-Hinton-agar. When
available break points were defined as described [19]. AMC,
amoxicillin/clavulanic acid; NA, not applicable; TMP/SMX,
trimethoprim/sulfamethoxazole, TZP, piperacillin/
tazobactam. †Break point for gentamicin was
used. ‡Break point for ciprofloxacin was used.
§Break point available for piperacillin
only. ¶Break point for doxycycline was used. #Intrinsic
resistance.
Seroprevalence
Of the 304 healthy schoolchildren for whom serum samples were tested for B.
pseudomallei antibodies, 143 (47.0%) were male. Details for this cohort
have been reported previously (15). For 43 (14.1%) children, an IHA titer was
detectable; titers ranged from 1:10 to 1:80 (median 1:10, interquartile range
1:10–1:20). For 5 (1.6%) children, IHA titer was
>1:40, which has been used as the cutoff value for
seropositivity (22). None of
the children had an IHA titer >1:160, which is considered by several centers in
Thailand to support a diagnosis of melioidosis in patients with clinical features
consistent with this diagnosis.
Environmental Isolates
The predominant soil type in this area of Gabon was ferralsol, which is red and
yellow weathered soil. The only exception was samples taken from a rice paddy near
Mouila village, where the soil was gleysol (clay, a hydric soil saturated with
groundwater long enough to develop a characteristic gleyic color pattern) (Table 2). B. pseudomallei was
isolated from 21 (3%) of 800 soil samples taken from 3 (38%) of the 8 sample sites;
the maximum number of positive samples for 1 site was 14 (14%) (Table 2). The biochemical profiles of all
isolates were in accordance with B. pseudomallei (API 20NE code
1156576). The antibiogram of B. pseudomallei soil strain C2 is shown
in Table 1.
Geographic features and distribution of Burkholderia
pseudomallei strains at 8 sampling sites in Moyen-Ogooué and
Ngounié Provinces, Gabon, 2012–2013*
Site
Nearest village
Elevation, m
Land use
Soil type
Soil description
Sample holes positive, %
A
Lambaréné, Albert Schweitzer
Hospital; lat. S 00°40′40.5, long. E
010°13′49.7
34
Football (soccer) field
Ferralsol
Yellowish-brown, clay fluvial sediments, not
strongly humic, some gravel, poorly sorted sediment, decalcified
14
B
Lambaréné, Adouma; lat. S
00°40′50.2, long. E 010°13′31.5
14
Riverbed that is dry most of the year
Ferralsol, clay, orange, dry
Brownish yellow, clay fluvial sediments,
moderately humic, some gravel, strong indicators of human
interference
0
C
Makouké; lat. S
00°28′30.8, long. E 010°24′34.7
20
Cattle ranch
Ferrasol, orange, little stones, hard,
rocky, less hard, orange
Yellowish brown, clay fluvial sediments, not
strongly humic, some gravel, poorly sorted sediment, decalcified
4
D
Lambaréné, Adiwa; lat. S
00°41′06.0, long. E 010°13′43.5
8
Next to school (with Bps IHA
positivity)
Ferralsol
Brownish yellow, clay fluvial sediments,
moderately humic, some gravel, strong indicators of human
interference
3
E
Lambaréné, Petit Paris 3; lat.
S010°42′40.4, long. E 010°15′20.7
35
Cattle ranch
Savannah/ferralsol
Yellowish gray, well-sorted clay, weakly
humic
0
F
Fougamou; lat. S 01°18′40.3,
long. E 010°37′14.4
88
Savannah, grassland
Savannah/ferralsol
Yellowish gray, well-sorted clay, weakly
humic
0
G
Massika II; lat. S 00°40′40.7,
long. E 010°13′51.4
55
Football pitch
Ferralsol
Reddish brown, clay fluvial sediments, not
strongly humic, sediment, decalcified
0
H
Mouila; lat. S 01°51′27.8,
long. E 011°02′37.7
92
Rice paddy
Gleysol
Greyish yellow clay with ferric concretions,
gleyic features, probably associated with rice cultivation
0
*lat., latitude; long., longitude.
The closely related B. thailandensis coexists with B.
pseudomallei in the soil in Southeast Asia and Australia and is generally
considered avirulent (5,28). We also identified
B. thailandensis in the soil of Gabon (Figure 2). This strain, termed B. thailandensis
soil strain D50, was positive by Bps latex agglutination. This B.
thailandensis strain, API 20NE code 1157577, was susceptible to
trimethoprim/sulfamethoxazole, amoxicillin/clavulanic acid, ceftazidime, and
meropenem (Table 1).
Phylogenetic tree of Burkholderia pseudomallei and B.
thailandensis strains from Gabon, 2012–2013. Phylogenetic
analysis by multilocus sequence typing amplification (MLST) of isolate Gb100
(from 62-year-old patient who died of melioidosis), B.
pseudomallei soil isolate C2 (sample collected at site C), and
B. thailandensis soil isolate D50 (sample collected at site
D), together with sequence types representing all B.
pseudomallei and B. thailandensis isolate
accessible in the MLST database. Phylogenetic tree was constructed by using the
neighbor-joining algorithm with the Kimura 2-parameter model. Bootstrap test
was for 500 repetitions. Sequence type labels were omitted for simplicity.
Position of the isolates from Gabon, including their closest relatives, are
indicated.
Genetics and Phylogeny of Burkholderia spp. Strains
The 3 isolates from Gabon contained previously described MLST alleles but belonged to
novel STs. The patient isolate Gb100 (ST1127) and soil isolate C2 (ST1128) were
single-locus variants and differed by 1 nt in the narK sequence
only. Patient isolate Gb100 was also a single-locus variant of ST707
(single-nucleotide substitution in ndh). The only B.
pseudomallei strain with ST707 in the database had been isolated in 2010
from a patient in the United Kingdom, 6 weeks after the patient had returned from a
trip to Nigeria (12). The
soil isolate C2 (ST1128) was a single-locus variant of ST7 (single-nucleotide
substitution in ndh) and ST879 (single-nucleotide substitution in
lipA). ST7 was represented by 2 isolates in the MSLT database,
both isolated in 1963 from patients in Vietnam. The B. pseudomallei
ST879 strain was isolated in 2011 from a patient in Spain, who had returned from a
trip through Madagascar and 14 countries in West Africa (11). The soil isolate D50 (ST1126) was a
single-locus variant of ST73. This ST is represented in the database by 2 B.
thailandensis strains, 1 isolated from a foal in France and 1 isolated
from the environment in Kenya. Phylogenetic analysis of the Gabon isolates together
with 971 STs obtained from the MLST database by using the aligned concatenated
sequences of the 7 loci in the neighbor-joining algorithm with the Kimura 2-parameter
model showed that the patient isolate Gb100 and soil isolate C2, found near the
community of the patient, grouped together with 7 STs. These 7 STs represented 10
B. pseudomallei strains isolated in Cambodia (2 strains), Vietnam
(2 strains), Niger, Nigeria, Spain (imported), France (2 strains [1 imported]), and
the United Kingdom (imported) (Figure 2). Again,
patient isolate Gb100 and soil isolate C2 are most closely related to ST879. Soil
isolate D50 grouped together with 3 STs representing 4 B.
thailandensis strains isolated from Kenya, France, the United States, and
Cambodia. Using this approach, we showed that the closest relatives of the strain
that infected and eventually killed the patient reported here were ST879 and the
strain isolated from soil around her community. Our whole-genome sequencing sample
data have been submitted to a project that is undertaking whole-genome sequencing on
a large number of B. pseudomallei isolates from around the world.
This approach is anticipated to offer superior resolution of the global phylogeny of
B. pseudomallei (9).
Discussion
We detected a case of melioidosis in a human in central Africa, confirmed the presence
of B. pseudomallei in the environment in Gabon, and isolated B.
thailandensis from an environmental sample from that part of the world. The
low rate of antibody seropositivity among healthy children combined with the low
prevalence of B. pseudomallei cultured from blood of patients in a
local hospital, however, suggest that melioidosis is rare in this setting.
Only 4 of the 13 melioidosis cases acquired by humans in Africa and reported in the
literature have been PCR confirmed (9–12,29–34). We show with phylogenetic analysis that the newly
identified patient isolate Gb100 groups with a B. pseudomallei isolate
from a patient from Spain who had traveled across West Africa and Madagascar (12). B.
pseudomallei seropositivity was reported during a World Health Organization
investigation into an outbreak of severe pneumonia in the northeastern of the Democratic
Republic of Congo (Eric Bertherat, pers. comm.) (35). However, in that study some of the B.
pseudomallei–seropositive cases diagnosed as melioidosis were later
diagnosed as plague, calling into question the value of serology-based testing in this
setting (35). The predominant
soil type at the sites from which B. pseudomallei was isolated was
similar to the soil type from which B. pseudomallei strains were
isolated in Cambodia (26,36). The low rate of B.
pseudomallei positivity per site points toward a relatively low abundance of
B. pseudomallei in Gabon soil when compared with highly
melioidosis-endemic areas in Southeast Asia and Australia (21,37). The true distribution of melioidosis in Africa
remains uncertain, but we now can expand this area toward the central African country of
Gabon.
The genus Burkholderia comprises >30 species, of which B.
pseudomallei and B. mallei are considered the most
pathogenic (2,38). The isolation of B.
thailandenis from soil in Gabon extends our knowledge of the geographic
distribution of this species. This strain was positive by Bps latex agglutination; this
finding is in agreement with previous findings of a B. thailandensis
strain from Thailand with a Bps-like capsular polysaccharide variant that also had a
positive Bps latex-agglutination result (39). Our phylogenic analysis shows a divergence between
the strain from Gabon and the original B. thailandenis E264 from
Thailand, which is the most studied strain (4,5). Evidence of the presence of this bacterium in Africa
will have implications for bacterial identification in clinical laboratories, diagnostic
serology assays, and environmental studies.
Our study has several limitations. B. pseudomallei serology can be
misleading; false- positive results are a major concern (40). Clearly, for assessing exposure to B.
pseudomallei, an accurate, inexpensive, simple serologic assay is needed. In
the interim, however, serologic evidence of exposure should be based on assays with
known sensitivity and specificity against culture-confirmed melioidosis, and, to our
understanding, the IHA is the best test for identifying melioidosis cases. Given the
nature of working in a resource-poor environment, only limited information is available
on the patient reported here (e.g., no imaging was performed to investigate the presence
of deeper abscesses). With regard to the environmental study, B.
pseudomallei is known for its capacity to survive in water and has been
reported to be present in the air during severe weather (17); we, however did not investigate its presence in
water and air in Gabon in this study. Furthermore, we cannot dismiss the possibility of
error during soil sampling although guidelines for environmental sampling of B.
pseudomallei were followed (17).
In summary, we identified B. pseudomallei and B.
thailandensis in the Gabon environment and discovered a novel B.
pseudomallei ST that can cause lethal septic shock. B.
pseudomallei is probably an underrecognized cause of disease in central
Africa. We propose that melioidosis occurs in central Africa but that it is unrecognized
because of the lack of diagnostic microbiology facilities.
Suggested citation for this article: Wiersinga WJ, Birnie E,
Weehuizen TA, Alabi AS, Huson MA, Huis in ’t Veld RAG, et al. Clinical,
environmental, and serologic surveillance studies of melioidosis in Gabon,
2012–2013. Emerg Infect Dis [Internet]. 2015 Jan [date
cited]. http://dx.doi.org/10.3201/eid2101.140762
These authors contributed equally to this article.
Acknowledgments
We thank our colleagues in the field for fruitful discussions leading towards this
project, Sebastiaan Stolp for help with the logistics concerning the soil sampling
study, Katja de Jong and Jacqueline Lankelma for help in the laboratory, and Matt T.
Holden for help with the genetic analysis.
This study was supported by the Netherlands Organization for Scientific Research (Veni
grant no. 91610008 to W.J.W.) and the Netherlands Organization for Health Research and
Development (ZonMW clinical fellowship grant no. 90700424 to W.J.W.). V.W. and D.L. work
at Mahidol-Oxford Tropical Medicine Research Unit funded by the Wellcome Trust of Great
Britain (no. 089275/Z/09/Z).
Dr. Wiersinga divides his time between patient care, teaching, and research at the
Academic Medical Center, Amsterdam. His research focus is sepsis.
ReferencesWiersingaWJ,
CurrieBJ,
PeacockSJ.
Melioidosis.N Engl J Med.
2012;367:1035–44.
10.1056/NEJMra120469922970946ChengAC,
CurrieBJ. Melioidosis:
epidemiology, pathophysiology, and management.Clin Microbiol Rev.
2005;18:383–416.
10.1128/CMR.18.2.383-416.200515831829Department of Health and Human Services, Centers
for Disease Control and Prevention. Possession, use, and transfer of
select agents and toxins; biennial review. Fed
Regist.2012;77:61083–115.BrettPJ,
DeshazerD, WoodsDE. Burkholderia
thailandensis sp. nov., a Burkholderia
pseudomallei–like species.Int J Syst Bacteriol.
1998;48:317–20.
10.1099/00207713-48-1-3179542103WiersingaWJ, de
VosAF, de
BeerR. Wieland
CW,
Roelofs
JJ,
Woods
DE, et al. Inflammation patterns induced by different
Burkholderia species in mice. Cell Microbiol.
2008;10:81–7.SmithMD, AngusBJ,
WuthiekanunV, WhiteNJ. Arabinose assimilation
defines a nonvirulent biotype of Burkholderia
pseudomallei.Infect Immun.
1997;65:4319–21
.9317042CurrieBJ, WardL, ChengAC. The epidemiology and
clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective
study.PLoS Negl Trop Dis.
2010;4:e900. 10.1371/journal.pntd.000090021152057RolimDB, VilarDC, SousaAQ. Miralles
IS,
de
Oliveira DC,
Harnett
G, et al. Melioidosis, northeastern Brazil. Emerg Infect Dis.
2005;11:1458–60.KatangweT,
PurcellJ,
Bar-ZeevN. Denis
B,
Montgomery J,
Alaerts
M, et al. Human melioidosis, Malawi, 2011. Emerg Infect Dis.
2013;19:981–4.CuadrosJ, GilH, MiguelJD. Marabé G,
Gómez-Herruz
TA,
Lobo
B, et al. Case report: melioidosis imported from West Africa to Europe.
Am J Trop Med Hyg. 2011;85:282–4.MorosiniMI,
QueredaC, GilH. Anda
P,
Núñez-Murga
M,
Cantón R, et al. Melioidosis in traveler from Africa to Spain.
Emerg Infect Dis. 2013;19:1656–9.SalamAP, KhanN,
MalnickH, KennaDT, DanceDA, KleinJL. Melioidosis acquired
by traveler to Nigeria.Emerg Infect Dis.
2011;17:1296–8.
10.3201/eid1707.11050221762592BatchelorBI, PaulJ,
TrakulsomboonS, MgongoM, DanceDA. Melioidosis survey in
Kenya.Trans R Soc Trop Med Hyg.
1994;88:181. 10.1016/0035-9203(94)90286-07518617CurrieBJ, DanceDA, ChengAC. The global
distribution of Burkholderia pseudomallei and melioidosis: an
update.Trans R Soc Trop Med Hyg.
2008;102:S1–4.
10.1016/S0035-9203(08)70002-619121666LellB,
FaucherJF,
MissinouMA. Borrmann
S,
Dangelmaier O,
Horton
J, et al. Malaria chemoprophylaxis with tafenoquine: a randomised
study. Lancet. 2000;355:2041–5.SuputtamongkolY, HallAJ, DanceDA. Chaowagul W,
Rajchanuvong A,
Smith
MD, et al. The epidemiology of melioidosis in Ubon Ratchatani,
northeast Thailand. Int J Epidemiol. 1994;23:1082–90.LimmathurotsakulD, DanceDA,
WuthiekanunV. Kaestli
M,
Mayo
M,
Warner
J, et al. Systematic review and consensus guidelines for environmental
sampling of Burkholderia pseudomallei PLoS Negl Trop Dis.
2013;7:e2105.WuthiekanunV,
ChantratitaN, DanceD,
LimmathurotsakulD,
PeacockSJ. SOP: latex agglutination technique
for the detection of Burkholderia pseudomallei2012
[cited 2014 May 1]. http://www.melioidosis.info/download.aspxJenneyAW, LumG, FisherDA,
CurrieBJ. Antibiotic
susceptibility of Burkholderia pseudomallei from tropical
northern Australia and implications for therapy of melioidosis.Int J Antimicrob Agents.
2001;17:109–13.
10.1016/S0924-8579(00)00334-411165114AlexanderAD,
HuxsollDL,
WarnerARJr, SheplerV, DorseyA. Serological diagnosis
of human melioidosis with indirect hemagglutination and complement fixation
tests.Appl Microbiol.
1970;20:825–33
.5530276WuthiekanunV,
PheaktraN,
PutchhatH. Sin
L,
Sen
B,
Kumar
V, et al. Burkholderia pseudomallei antibodies in
children, Cambodia. Emerg Infect Dis. 2008;14:301–3.ChengAC,
O'BrienM,
FreemanK, LumG, CurrieBJ. Indirect
hemagglutination assay in patients with melioidosis in northern
Australia.Am J Trop Med Hyg.
2006;74:330–4
.16474092LimmathurotsakulD,
WuthiekanunV,
ChantratitaN. Wongsuvan G,
Amornchai P,
Day
NP, et al. Burkholderia pseudomallei is spatially
distributed in soil in northeast Thailand. PLoS Negl Trop Dis.
2010;4:e694.WuthiekanunV,
AnuntagoolN, WhiteNJ,
SirisinhaS. Short report: a rapid
method for the differentiation of Burkholderia pseudomallei and
Burkholderia thailandensis.Am J Trop Med Hyg.
2002;66:759–61
.12224587AmornchaiP,
ChierakulW,
WuthiekanunV. Mahakhunkijcharoen Y,
Phetsouvanh R,
Currie
BJ, et al. Accuracy of Burkholderia pseudomallei
identification using the API 20NE system and a latex agglutination test. J Clin
Microbiol. 2007;45:3774–6.JonesA,
Breuning-MadsonH,
BrossardM. Soil atlas of Africa. European
Commission. Luxembourg (Belgium): Publications Office of the European Union;
2013.GodoyD, RandleG,
SimpsonAJ. Aanensen
DM,
Pitt
TL,
Kinoshita R, et al. Multilocus sequence typing and evolutionary
relationships among the causative agents of melioidosis and glanders,
Burkholderia pseudomallei and Burkholderia
mallei J Clin Microbiol. 2003;41:2068–79.BrettPJ,
DeshazerD, WoodsDE. Characterization of
Burkholderia pseudomallei and Burkholderia
pseudomallei–like strains.Epidemiol Infect.
1997;118:137–48.
10.1017/S095026889600739X9129590BremmelgaardA,
BygbjergI, HoibyN. Microbiological and
immunological studies in a case of human melioidosis diagnosed in
Denmark.Scand J Infect Dis.
1982;14:271–5
.7163779WallRA, MabeyDC,
CorrahPT,
PetersL. A case of melioidosis
in West Africa.J Infect Dis.
1985;152:424–5.
10.1093/infdis/152.2.424a4031552IssackMI,
BundhunCD,
GokhoolH. Melioidosis in
Mauritius.Emerg Infect Dis.
2005;11:139–40.
10.3201/eid1101.04060515705340MartinetO, Pac
SooAM,
KnezynskiM. Melioidosis: regarding
a case acquired in Madagascar and two nosocomial cases[in French]Bull Soc Pathol Exot.
2004;97:366–70.BorgheriniG,
PoubeauP,
PaganinF. Picot
S,
Michault
A,
Thibault
F, et al. Melioidosis: an imported case from Madagascar. J Travel Med.
2006;13:318–20.AmezyaneT,
LecoulesS,
AlgayresJP. Mycotic iliac aneurysm
associated with Burkholderia pseudomallei.Int J Infect Dis.
2010;14(Suppl
3):e381–2. 10.1016/j.ijid.2009.07.00819897393BertheratE,
ThullierP, ShakoJC. England
K,
Koné ML,
Arntzen
L, et al. Lessons learned about pneumonic plague diagnosis from two
outbreaks, Democratic Republic of the Congo. Emerg Infect Dis.
2011;17:778–84.RattanavongS,
WuthiekanunV, LanglaS. Amornchai P,
Sirisouk
J,
Phetsouvanh R, et al. Randomized soil survey of the distribution of
Burkholderia pseudomallei in rice fields in Laos. Appl Environ
Microbiol. 2011;77:532–6.KaestliM, MayoM,
HarringtonG. Ward
L,
Watt
F,
Hill
JV, et al. Landscape changes influence the occurrence of the
melioidosis bacterium Burkholderia pseudomallei in soil in northern
Australia. PLoS Negl Trop Dis. 2009;3:e364.UsseryDW, KiilK,
LagesenK,
Sicheritz-PontenT, BohlinJ,
WassenaarTM. The genus
Burkholderia: analysis of 56 genomic
sequences.Genome Dyn.
2009;6:140–57.
10.1159/00023576819696499HantrakunV,
RongkardP,
AmonchiP,
SarunpornT, LanglaS,
WuthiekanunV, Presence of environmental
B. pseudomallei, B. thailandensis and putative B.
thailandensis with B. ps–like CPS variant in east
Thailand. Abstract in: Proceedings of the 7th World Melioidosis Congress;
2013 Sep 18–20; Bangkok, Thailand.PeacockSJ, ChengAC,
CurrieBJ, DanceDA. The use of positive
serological tests as evidence of exposure to Burkholderia
pseudomallei.Am J Trop Med Hyg.
2011;84:1021–2.
10.4269/ajtmh.2011.11-0114a21633045